Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030933.pdf 0000899243-18-030933.rtf View HTML
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030934.pdf 0000899243-18-030934.rtf View HTML
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030937.pdf 0000899243-18-030937.rtf View HTML
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030935.pdf 0000899243-18-030935.rtf View HTML
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030939.pdf 0000899243-18-030939.rtf View HTML
December 13, 2018	3	Initial filing by director officer or owner of more than ten percent.	0000899243-18-030940.pdf 0000899243-18-030940.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030946.pdf 0000899243-18-030946.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030947.pdf 0000899243-18-030947.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030945.pdf 0000899243-18-030945.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030948.pdf 0000899243-18-030948.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax